Gene: GALE
Official Full Name: UDP-galactose-4-epimeraseprovided by HGNC
Gene Summary: This gene encodes UDP-galactose-4-epimerase which catalyzes two distinct but analogous reactions: the epimerization of UDP-glucose to UDP-galactose, and the epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The bifunctional nature of the enzyme has the important metabolic consequence that mutant cells (or individuals) are dependent not only on exogenous galactose, but also on exogenous N-acetylgalactosamine as a necessary precursor for the synthesis of glycoproteins and glycolipids. Mutations in this gene result in epimerase-deficiency galactosemia, also referred to as galactosemia type 3, a disease characterized by liver damage, early-onset cataracts, deafness and cognitive disability, with symptoms ranging from mild ('peripheral' form) to severe ('generalized' form). Multiple alternatively spliced transcripts encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37753 | GALE Knockout cell line (HeLa) | Human | GALE | 1:3~1:6 | Negative | Online Inquiry |
KO37754 | GALE Knockout cell line (HCT 116) | Human | GALE | 1:2~1:4 | Negative | Online Inquiry |
KO37755 | GALE Knockout cell line (HEK293) | Human | GALE | 1:3~1:6 | Negative | Online Inquiry |
KO37756 | GALE Knockout cell line (A549) | Human | GALE | 1:3~1:4 | Negative | Online Inquiry |
GALE Gene Knockout Cell Lines are expertly engineered cell lines that have had the GALE (UDP-galactose-4-epimerase) gene specifically knocked out using CRISPR-Cas9 technology. This innovative approach enables researchers to study the functional role of the GALE enzyme in cellular metabolism, particularly in galactose metabolism and the synthesis of glycoproteins and glycolipids. By creating these knockout models, scientists can observe the phenotypic consequences of GALE deficiency, providing insights into the implications of reduced enzyme activity on cellular functions, genetic diseases, and potential therapeutic interventions.
The key functions of GALE involve the reversible conversion of UDP-galactose and UDP-glucose, pivotal in multiple biochemical pathways. By knocking out GALE, researchers can elucidate the pathways and mechanisms that alter due to its absence, offering new avenues for investigating hereditary galactosemia and other related metabolic disorders. These insights are particularly valuable in both basic research settings and clinical investigations into therapies that target metabolic deficiencies.
Compared to alternative methods of studying gene function, such as overexpression or pharmacological inhibition, GALE Gene Knockout Cell Lines facilitate a more accurate representation of the gene's specific roles and interactions within the cellular environment. This specificity can lead to more reliable data, ultimately enhancing translational applications in clinical settings.
Furthermore, the value of GALE Gene Knockout Cell Lines lies in their ability to serve as a standard tool for pharmaceutical development. They provide a reliable platform for screening potential drug candidates that could mitigate the effects of GALE deficiency. Given the rising interest in personalized medicine and targeted therapies, researchers relying on these cell lines can conduct more relevant and robust experiments that may lead to significant breakthroughs.
Our company prides itself on its advanced genetic engineering capabilities and commitment to producing high-quality biological products to empower researchers and clinicians. By providing GALE Gene Knockout Cell Lines, we support the scientific community in their quest to uncover the mysteries of gene function and develop innovative medical solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.